Aim is to move above 20% EBITDA, says GSK Pharma

CNBC-TV18 2019-08-19

Views 8

From the Motilal Oswal 15th Investor Conference, Annaswamy Vaidheesh, vice president P-South Asia and India MD of Glaxosmithkline Pharmaceuticals shared his views and outlook.

Share This Video


Download

  
Report form
RELATED VIDEOS